Analysts weigh in on Myriad Genetics, Inc.’s (NASDAQ: MYGN ) first-quarter report
You may know, Myriad Genetics, Inc. (NASDAQ: MYGN ) just released its latest first-quarter results, posting some very strong numbers. Myriad Genetics beat expectations with revenue of $202 million, beating …